🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

393,17 USD

Máx. histórico

447,03

14 días

Split 2:1 del 22/11/1999

Caída desde máximo

-12,05%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-10,08%

Cierre anterior

437,23

Rango de hoy

391,17 – 410,03

Volumen hoy

6.589.429

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
24,44 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 horas
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,53%
Fecha de pago Importe por participación
21/08/2026 2,5200 USD
15/05/2026 2,5200 USD
13/02/2026 2,5200 USD
21/11/2025 2,3800 USD
22/08/2025 2,3800 USD
16/05/2025 2,3800 USD
14/02/2025 2,3800 USD
18/11/2024 2,2500 USD
16/08/2024 2,2500 USD
16/05/2024 2,2500 USD
15/02/2024 2,2500 USD
16/11/2023 2,1300 USD
17/08/2023 2,1300 USD
17/05/2023 2,1300 USD
14/02/2023 2,1300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
22/11/1999 2:1
01/03/1999 2:1
16/08/1995 2:1
11/09/1991 3:1
13/08/1990 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/04/2000 52,88 61,30 52,50 57,25 +5,41% 16,64% 31.026.200
25/04/2000 53,19 54,56 51,25 54,31 +5,85% 6,23% 11.171.500
24/04/2000 53,31 53,80 50,00 51,31 -4,98% 7,12% 11.779.300
20/04/2000 56,75 57,25 53,19 54,00 -3,57% 7,16% 7.848.300
19/04/2000 58,44 59,94 55,25 56,00 -4,07% 8,02% 9.010.200
18/04/2000 54,77 58,50 54,13 58,38 +9,37% 7,99% 9.480.500
17/04/2000 52,38 54,25 50,00 53,38 +1,18% 8,11% 12.355.900
14/04/2000 56,69 58,00 52,13 52,75 -8,76% 10,36% 12.667.000
13/04/2000 59,56 61,38 56,50 57,81 -0,99% 8,18% 8.131.900
12/04/2000 60,13 61,50 58,19 58,39 -1,24% 5,51% 7.345.800
11/04/2000 58,00 60,38 57,00 59,13 +0,42% 5,82% 7.586.200
10/04/2000 62,00 63,75 58,75 58,88 -3,38% 8,06% 9.390.100
07/04/2000 63,44 64,38 60,25 60,94 -2,21% 6,50% 8.580.600
06/04/2000 61,89 64,38 61,50 62,31 +4,51% 4,65% 10.843.500
05/04/2000 56,31 62,25 56,00 59,63 +5,65% 11,10% 10.977.800
04/04/2000 60,13 60,13 53,81 56,44 -4,95% 10,50% 14.755.200
03/04/2000 61,00 61,94 58,13 59,38 -3,26% 6,25% 6.449.800
31/03/2000 61,63 63,00 59,63 61,38 +1,87% 5,48% 7.864.600
30/03/2000 61,56 64,31 59,00 60,25 -3,21% 8,63% 9.182.700
29/03/2000 64,94 65,88 61,69 62,25 -0,90% 6,45% 10.524.700
28/03/2000 61,25 65,75 60,41 62,81 +4,04% 8,72% 18.037.600
27/03/2000 55,13 61,00 55,13 60,38 +10,65% 10,66% 15.924.900
24/03/2000 58,25 58,42 52,75 54,56 -5,42% 9,74% 21.633.800
23/03/2000 58,13 58,50 56,81 57,69 -6,58% 2,90% 20.064.100
22/03/2000 61,69 63,13 60,00 61,75 +1,02% 5,07% 11.226.000
21/03/2000 58,13 61,50 55,13 61,13 +5,39% 10,97% 16.598.600
20/03/2000 62,25 62,38 56,94 58,00 -8,12% 8,73% 20.278.200
17/03/2000 64,25 65,19 62,19 63,13 -2,51% 4,67% 12.260.600
16/03/2000 62,50 65,50 61,13 64,75 +10,68% 7,00% 18.216.200
15/03/2000 57,19 59,38 56,00 58,50 +11,96% 5,90% 33.529.500